-
- Patient Homepage
-
- HCP Homepage
-
- Patient Homepage – Mobile
-
- HCP Homepage – Mobile
Mylotarg Now Approved Pages
Brand: Mylotarg (gemtuzumab ozogamicin), Intravenous Infusion
Parent Company: Pfizer
Drug Type: Boxed Warning
Drug Category: Oncology
Campaign: now-approved
Targeting: HCPs, Patients
Patient Website: https://www.mylotarg.com/
HCP Website: https://www.mylotarghcp.com/